Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam in pediatric heterozygous familial hypercholesterolemia
2005-003511-75Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of colesevelam in familial hypercholesterolemia (FH) (3 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Percent change from baseline in LDL-C at 8 weeks. Started Sep 2005; status: completed.
02
Drugs
colesevelam
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2005-003511-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003511-75.